HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$0.32
Day range
$0.30 - $0.32
Year range
$0.28 - $4.30
Market cap
7.80M USD
Avg Volume
2.33M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 69.00K | -65.15% |
Operating expense | 7.61M | -28.16% |
Net income | -5.76M | 38.82% |
Net profit margin | -8.34K | -75.57% |
Earnings per share | — | — |
EBITDA | -7.54M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.65M | -49.24% |
Total assets | 44.72M | -48.39% |
Total liabilities | 5.84M | -50.45% |
Total equity | 38.88M | — |
Shares outstanding | 25.47M | — |
Price to book | 0.16 | — |
Return on assets | -37.28% | — |
Return on capital | -45.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.76M | 38.82% |
Cash from operations | -10.80M | -27.36% |
Cash from investing | 4.68M | -75.42% |
Cash from financing | -34.00K | -1,600.00% |
Net change in cash | -6.16M | -158.49% |
Free cash flow | -10.65M | -385.56% |
About
Founded
2003
Headquarters
Website
Employees
13
